What is the risk of re‑operation after surgery for pelvic organ prolapse?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Risk of Re-operation After Pelvic Organ Prolapse Surgery

The reoperation rate after pelvic organ prolapse surgery is approximately 29% over a lifetime, with 5-year reoperation rates ranging from 6-11% depending on patient factors, though rates vary significantly based on surgical approach and patient characteristics 1.

Overall Reoperation Rates

The most comprehensive data from the 2022 ACR guidelines indicates that the lifetime risk of undergoing surgery for POP is 11%, with a reoperation rate as high as 29% 1. More recent long-term follow-up data from a nationwide Finnish cohort with mean 7.4-year follow-up shows:

  • Overall reoperation rate: 13% across all surgical approaches 2
  • Native tissue repair: 13.9%
  • Transvaginal mesh: 10.1%
  • Abdominal mesh: 12.1%

These rates were not statistically different between approaches (p=0.09) 2.

Time-Specific Reoperation Risks

Short to medium-term rates:

  • 1-year reoperation rate: 2.6-3.7% (depending on BMI) 3
  • 2-year surgical failure rate: 9.3% after laparoscopic sacrocolpopexy 4
  • 5-year reoperation rate: 6.1-11.2% (depending on BMI) 3

The majority of reoperations occur within the first 2-3 years post-surgery, with the anterior compartment being the most common site requiring revision 2, 4.

Key Risk Factors for Reoperation

Patient-specific factors that significantly increase reoperation risk:

  • Body Mass Index (BMI): Women with BMI ≥35 have nearly doubled risk of reoperation within 5 years compared to BMI <25 3

    • BMI 30-34.9: aHR 1.34 (95% CI 1.04-1.71)
    • BMI ≥35: aHR 1.77 (95% CI 1.17-2.67) for same compartment 3
    • For adjacent compartment after anterior repair: BMI ≥35 aHR 2.64 (95% CI 1.36-5.14) 3

  • Advanced age: Older age is an independent risk factor for recurrence 5

  • Higher parity: Multiple deliveries independently increase recurrence risk 5

  • Preoperative prolapse severity: Stage IV prolapse has 3.5-fold increased risk (OR 3.5,95% CI 1.1-10.8) 4

  • Surgical complexity: Combined posterior and apical compartment surgery increases reoperation risk (aOR 1.95% CI 1.30-2.92) 2

  • Pelvic floor muscle weakness: Reduced systolic pressure in type II muscle fibers predicts higher recurrence 5

Patterns of Recurrence by Surgical Approach

The site of reoperation differs significantly based on initial surgery:

  • After native tissue repair: Most reoperations involve anterior or apical compartments 2
  • After transvaginal mesh: Reoperations primarily involve posterior or apical compartments 2
  • After abdominal mesh: Similar to native tissue, anterior or apical repairs most common 2

Mesh is used in 40% of all reoperations, regardless of initial approach 2.

Subjective Recurrence vs. Anatomical Failure

Up to one-third of women report symptoms of vaginal bulging during follow-up, though this is significantly lower after transvaginal mesh surgery at 2- and 5-year follow-ups 2. This highlights the discrepancy between anatomical success and patient-reported outcomes.

In uterine-preserving surgery specifically:

  • Subjective failure: 13.0%
  • Anatomical failure: 8.7%
  • Composite failure: 16.6% 6

Impact of Concomitant Hysterectomy

Concomitant hysterectomy during initial POP surgery is protective against reoperation, with a hazard ratio of 0.51 (95% CI 0.49-0.53) 7. This represents approximately 50% reduction in reoperation risk when hysterectomy is performed with the initial prolapse repair.

Clinical Implications

Common pitfalls to avoid:

  1. Underestimating BMI impact: Women with BMI ≥35 require intensive preoperative counseling about their substantially elevated reoperation risk, particularly for anterior compartment repairs 3

  2. Incomplete initial repair: Single-compartment repairs may miss occult prolapse in other compartments, leading to earlier symptomatic failure 2

  3. Inadequate preoperative assessment: Failure to identify stage IV prolapse or multiple risk factors leads to unrealistic patient expectations 4

The overall 4.4% reoperation rate for recurrent prolapse reported in the large French cohort 7 likely underestimates true reoperation rates, as this only captured hospital-based procedures and may miss outpatient or delayed reoperations beyond the study period.

References

1
Guideline

acr appropriateness criteria® pelvic floor dysfunction in females.

Journal of the American College of Radiology, 2022

Related Questions

What discharge medications should be prescribed for a patient who has just undergone abdominal wall repair with mesh placement?
Does dietary sugar cause a pelvic organ prolapse to spontaneously reduce?
What is the standard of care for managing a pessary in an elderly woman residing in a memory‑care facility with pelvic organ prolapse?
In a patient undergoing a vaginal sacrocolpopexy 18 months after a failed vaginal apex repair, will using a tension‑free polypropylene mesh complicate the vaginal vault repair, and could a displaced bladder cause additional complications during bladder surgery?
What is the recommended management for an asymptomatic cystocele in a woman?
In a clinically stable 5-year-old who sustained a witnessed fall, has had no loss of consciousness or focal neurologic findings, but has vomited twice in the past four hours, what is the recommended management?
What is the highest risk factor for surgical site infection after an abdominal hysterectomy?
How does diabetes affect the risk of surgical site infection after abdominal hysterectomy and how should peri‑operative glycemic control be managed?
What syndrome is associated with monosomy X, delayed puberty, growth delay, and increased risk of gonadoblastoma?
What are the diagnostic criteria for post‑molar gestational trophoblastic neoplasia after dilation and curettage for a complete mole?
What are the effects of rapidly administering ketamine intravenously?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.